About Clorox Company (The) (NYSE:CLX)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International. Its Cleaning segment consists of laundry, home care and professional products marketed and sold in the United States. Its Household segment consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Its Lifestyle segment consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the United States. Its International segment consists of products sold outside the United States. It markets some of the consumer brand names, such as namesake bleach and cleaning products, Pine-Sol cleaners, Liquid-Plumr clog removers and Kingsford charcoal.
Industry, Sector and Symbol:
- Sector: Consumer Staples
- Industry: Household Products
- Sub-Industry: Household Products
- Symbol: NYSE:CLX
- CUSIP: 18905410
- Web: www.thecloroxcompany.com
- Market Cap: $16.49 billion
- Outstanding Shares: 129,068,000
- 50 Day Moving Avg: $132.37
- 200 Day Moving Avg: $134.16
- 52 Week Range: $111.24 - $141.76
Sales & Book Value:
- Trailing P/E Ratio: 23.95
- Foreward P/E Ratio: 21.22
- P/E Growth: 3.50
- Annual Revenue: $5.97 billion
- Price / Sales: 2.76
- Book Value: $4.20 per share
- Price / Book: 30.42
- Annual Dividend: $3.36
- Dividend Yield: 2.6%
- EBITDA: $1.26 billion
- Net Margins: 11.74%
- Return on Equity: 190.67%
- Return on Assets: 15.74%
- Debt-to-Equity Ratio: 2.57%
- Current Ratio: 0.84%
- Quick Ratio: 0.58%
- Average Volume: 761,343 shs.
- Beta: 0.39
- Short Ratio: 6.83
Frequently Asked Questions for Clorox Company (The) (NYSE:CLX)
What is Clorox Company (The)'s stock symbol?
Clorox Company (The) trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."
How often does Clorox Company (The) pay dividends? What is the dividend yield for Clorox Company (The)?
Clorox Company (The) declared a quarterly dividend on Wednesday, September 13th. Shareholders of record on Wednesday, October 25th will be paid a dividend of $0.84 per share on Monday, November 13th. This represents a $3.36 annualized dividend and a yield of 2.63%. The ex-dividend date is Tuesday, October 24th. View Clorox Company (The)'s Dividend History.
How were Clorox Company (The)'s earnings last quarter?
Clorox Company (The) (NYSE:CLX) posted its earnings results on Thursday, August, 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm's revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 earnings per share. View Clorox Company (The)'s Earnings History.
When will Clorox Company (The) make its next earnings announcement?
What guidance has Clorox Company (The) issued on next quarter's earnings?
Clorox Company (The) updated its FY18 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $5.52-5.72 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.69. The company issued revenue guidance of +2-4% to ~$6.09-6.21 billion, compared to the consensus revenue estimate of $6.16 billion.
Where is Clorox Company (The)'s stock going? Where will Clorox Company (The)'s stock price be in 2017?
10 analysts have issued 12 month price objectives for Clorox Company (The)'s shares. Their forecasts range from $76.00 to $150.00. On average, they anticipate Clorox Company (The)'s stock price to reach $124.33 in the next twelve months. View Analyst Ratings for Clorox Company (The).
Who are some of Clorox Company (The)'s key competitors?
Some companies that are related to Clorox Company (The) include Monster Beverage Corporation (MNST), Kao Corp. (KCRPY), General Mills (GIS), Heineken NV (HEINY), Sysco Corporation (SYY), Tyson Foods (TSN), Ahold NV (ADRNY), Archer-Daniels-Midland Company (ADM), Kirin Holdings (KNBWY), Brown Forman Corporation (BF.A), Brown Forman Corporation (BF.B), Coca-Cola European Partners PLC (CCE), Newell Brands (NWL), Fomento Economico Mexicano S.A.B. de C.V. (FMX), Carlsberg A/S (CABGY), Molson Coors Brewing Company (TAP), Hershey Company (The) (HSY) and Hormel Foods Corporation (HRL).
Who are Clorox Company (The)'s key executives?
Clorox Company (The)'s management team includes the folowing people:
- Benno O. Dorer, Chairman of the Board, Chief Executive Officer
- Stephen M. Robb, Chief Financial Officer, Executive Vice President
- Dawn C. Willoughby, Chief Operating Officer, Executive Vice President
- Laura Stein J.D., Executive Vice President, General Counsel - Corporate Affairs
- James E. Foster, Executive Vice President - Product Supply, Enterprise Performance and IT
- Manjit Singh, Senior Vice President, Chief Information Officer
- Eric H. Reynolds, Senior Vice President, Chief Marketing Officer
- Jon M. Balousek, Senior Vice President, General Manager - Specialty Division
- Linda Rendle, Senior Vice President, General Manager - Cleaning Division
- William S. Bailey, Senior Vice President – Corporate Business Development
Who owns Clorox Company (The) stock?
Clorox Company (The)'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include APG Asset Management N.V. (1.01%), Shell Asset Management Co. (0.09%), PGGM Investments (0.04%), State Treasurer State of Michigan (0.03%), Fisher Asset Management LLC (0.01%) and Hall Capital Management Co. Inc. (0.01%). Company insiders that own Clorox Company (The) stock include A D David Mackay, Dawn C Willoughby, Jacqueline P Kane, James E Foster, Jon M Balousek, Laura Stein, Nikolaos A Vlahos, Stephen Robb and Thomas D Johnson. View Institutional Ownership Trends for Clorox Company (The).
Who sold Clorox Company (The) stock? Who is selling Clorox Company (The) stock?
Clorox Company (The)'s stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Carnick & Kubik Group LLC, State Treasurer State of Michigan and Bridges Investment Counsel Inc.. Company insiders that have sold Clorox Company (The) stock in the last year include Dawn C Willoughby, James E Foster and Jon M Balousek. View Insider Buying and Selling for Clorox Company (The).
Who bought Clorox Company (The) stock? Who is buying Clorox Company (The) stock?
Clorox Company (The)'s stock was acquired by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Shell Asset Management Co., Fisher Asset Management LLC, Howe & Rusling Inc., Oakbrook Investments LLC, Assenagon Asset Management S.A., Honkamp Krueger Financial Services Inc. and Hall Capital Management Co. Inc.. View Insider Buying and Selling for Clorox Company (The).
How do I buy Clorox Company (The) stock?
Shares of Clorox Company (The) can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Clorox Company (The)'s stock price today?
MarketBeat Community Rating for Clorox Company (The) (NYSE CLX)MarketBeat's community ratings are surveys of what our community members think about Clorox Company (The) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Clorox Company (The) stock can currently be purchased for approximately $127.77.
Consensus Ratings for Clorox Company (The) (NYSE:CLX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||9 Hold Ratings, 1 Buy Rating|
|Consensus Rating:||Hold (Score: 2.10)|
|Consensus Price Target: ||$124.33 (2.69% downside)|Consensus Price Target History for Clorox Company (The) (NYSE:CLX)
Analysts' Ratings History for Clorox Company (The) (NYSE:CLX)
(Data available from 10/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/8/2017||Royal Bank Of Canada||Reiterated Rating||Hold||$115.00||N/A|
|10/6/2017||Jefferies Group LLC||Reiterated Rating||Hold||$137.00 -> $132.00||N/A|
|10/5/2017||BMO Capital Markets||Reiterated Rating||Buy||$150.00||N/A|
|8/4/2017||Barclays PLC||Reiterated Rating||Hold -> Equal Weight||$140.00 -> $136.00||Low|
|7/22/2017||Deutsche Bank AG||Reiterated Rating||Hold||$126.00 -> $137.00||Low|
|4/7/2017||Citigroup Inc.||Boost Price Target||Neutral||$75.00 -> $76.00||Low|
|3/21/2017||J P Morgan Chase & Co||Initiated Coverage||Neutral -> Neutral||$136.00||Low|
|2/11/2017||B. Riley||Reiterated Rating||Neutral||$125.00||N/A|
|12/16/2016||Morgan Stanley||Upgrade||Underweight -> Equal Weight||$112.00||N/A|
|11/15/2016||Wells Fargo & Company||Reiterated Rating||Market Perform||N/A|
|9/16/2016||Atlantic Securities||Upgrade||Hold -> Buy||$144.00||N/A|
|8/4/2016||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Neutral||$130.00||N/A|
|2/26/2016||Sterne Agee CRT||Downgrade||Buy -> Neutral||N/A|
|11/3/2015||Sanford C. Bernstein||Boost Price Target||Market-Perform||$111.00 -> $116.00||N/A|
Earnings History for Clorox Company (The) (NYSE:CLX)Earnings History by Quarter for Clorox Company (The) (NYSE CLX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/3/2017||Q4 2017||$1.49||$1.53||$1.65 billion||$1.65 billion||View||Listen|
|5/3/2017||Q3 2017||$1.30||$1.31||$1.48 billion||$1.48 billion||View||Listen|
|2/3/2017||Q217||$1.22||$1.25||$1.41 billion||$1.41 billion||View||N/A|
|11/2/2016||Q117||$1.42||$1.36||$1.24 billion||$1.44 billion||View||N/A|
|8/3/2016||Q416||$1.28||$1.26||$1.58 billion||$1.60 billion||View||Listen|
|5/3/2016||Q316||$1.11||$1.21||$1.41 billion||$1.43 billion||View||N/A|
|2/4/2016||Q216||$1.05||$1.14||$1.35 billion||$1.35 billion||View||Listen|
|11/2/2015||Q116||$1.18||$1.32||$1.37 billion||$1.39 billion||View||Listen|
|8/3/2015||Q415||$1.37||$1.44||$1.52 billion||$1.56 billion||View||N/A|
|5/1/2015||Q315||$1.10||$1.08||$1.38 billion||$1.40 billion||View||Listen|
|2/4/2015||Q215||$0.90||$0.97||$1.30 billion||$1.35 billion||View||Listen|
|10/31/2014||Q115||$1.03||$1.10||$1.33 billion||$1.35 billion||View||Listen|
|8/1/2014||Q4||$1.34||$1.40||$1.52 billion||$1.51 billion||View||Listen|
|5/1/2014||Q314||$1.08||$1.18||$1.43 billion||$1.39 billion||View||N/A|
|2/4/2014||Q214||$0.91||$0.88||$1.31 billion||$1.33 billion||View||N/A|
|10/31/2013||Q114||$1.01||$1.04||$1.35 billion||$1.36 billion||View||N/A|
|8/1/2013||Q4 2013||$1.34||$1.38||$1.57 billion||$1.55 billion||View||N/A|
|5/1/2013||Q3 2013||$1.06||$1.00||$1.44 billion||$1.41 billion||View||N/A|
|2/4/2013||Q2 2013||$0.80||$0.90||$1.27 billion||$1.33 billion||View||N/A|
|10/31/2012||Q113||$0.95||$1.01||$1.35 billion||$1.34 billion||View||N/A|
Earnings Estimates for Clorox Company (The) (NYSE:CLX)
2017 EPS Consensus Estimate: $5.49
2018 EPS Consensus Estimate: $5.66
2019 EPS Consensus Estimate: $5.88
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Clorox Company (The) (NYSE:CLX)
|Dividend Growth:||5.20% (3 Year Average)|
|Payout Ratio:||63.04% (Trailing 12 Months of Earnings) |
59.68% (Based on This Year's Estimates)
55.81% (Based on Next Year's Estimates)
|Track Record:||39 Years of Consecutive Dividend Growth|
Dividend History by Quarter for Clorox Company (The) (NYSE CLX)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Clorox Company (The) (NYSE:CLX)
Insider Ownership Percentage: 1.00%Insider Trades by Quarter for Clorox Company (The) (NYSE:CLX)
Institutional Ownership Percentage: 71.22%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/29/2017||Dawn C. Willoughby||COO||Sell||2,158||$138.00||$297,804.00|| |
|8/23/2017||James E Foster||EVP||Sell||9,861||$138.51||$1,365,847.11|| |
|8/23/2017||Jon M Balousek||SVP||Sell||9,223||$138.87||$1,280,798.01|| |
|12/1/2016||A D David Mackay||Director||Buy||5,000||$114.90||$574,500.00|| |
|9/2/2016||Laura Stein||EVP||Sell||38,882||$131.69||$5,120,370.58|| |
|8/29/2016||Jon M Balousek||SVP||Sell||5,136||$131.14||$673,535.04|| |
|8/17/2016||Dawn C Willoughby||COO||Sell||10,617||$131.01||$1,390,933.17|| |
|8/10/2016||Nikolaos A. Vlahos||COO||Sell||925||$133.07||$123,089.75|| |
|5/10/2016||Nikolaos A Vlahos||COO||Sell||2,151||$132.25||$284,469.75|| |
|2/24/2016||Dawn C Willoughby||COO||Sell||1,550||$129.00||$199,950.00|| |
|2/8/2016||Nikolaos A. Vlahos||COO||Sell||8,589||$126.60||$1,087,367.40|| |
|12/7/2015||Jon M Balousek||SVP||Sell||1,488||$128.69||$191,490.72|| |
|12/4/2015||Jacqueline P Kane||EVP||Sell||852||$127.55||$108,672.60|| |
|12/3/2015||Thomas D Johnson||VP||Sell||908||$126.09||$114,489.72|| |
|11/27/2015||Jacqueline P Kane||EVP||Sell||2,160||$125.45||$270,972.00|| |
|11/25/2015||Thomas D. Johnson||VP||Sell||12,679||$125.04||$1,585,382.16|| |
|11/19/2015||Laura Stein||EVP||Sell||12,700||$124.42||$1,580,134.00|| |
|11/17/2015||Stephen Robb||CFO||Sell||30,496||$122.02||$3,721,121.92|| |
|11/12/2015||James E. Foster||EVP||Sell||5,684||$122.24||$694,812.16|| |
|11/11/2015||Laura Stein||EVP||Sell||17,577||$124.21||$2,183,239.17|| |
|11/4/2015||Dawn C. Willoughby||COO||Sell||29,349||$124.06||$3,641,036.94|| |
|11/4/2015||Laura Stein||EVP||Sell||8,716||$124.50||$1,085,142.00|| |
|10/6/2015||Stephen Robb||CFO||Sell||19,125||$119.00||$2,275,875.00|| |
|9/25/2015||Jacqueline P Kane||EVP||Sell||2,340||$115.00||$269,100.00|| |
|9/25/2015||Stephen Robb||CFO||Sell||21,020||$115.00||$2,417,300.00|| |
|9/18/2015||Stephen Robb||CFO||Sell||8,500||$113.85||$967,725.00|| |
|9/17/2015||Jacqueline P Kane||EVP||Sell||5,027||$115.00||$578,105.00|| |
|9/14/2015||James E. Foster||EVP||Sell||11,999||$109.34||$1,311,970.66|| |
|9/8/2015||Jon M Balousek||SVP||Sell||1,294||$111.38||$144,125.72|| |
|9/2/2015||Frank A Tataseo||EVP||Sell||3,673||$110.25||$404,948.25|| |
|8/28/2015||Thomas D Johnson||VP||Sell||1,051||$111.34||$117,018.34|| |
|8/27/2015||James E Foster||EVP||Sell||3,000||$111.39||$334,170.00|| |
|8/20/2015||Nikolaos A Vlahos||COO||Sell||4,800||$116.12||$557,376.00|| |
|6/16/2015||Jeffrey T Klenda||Director||Buy||394,257||$0.20||$78,851.40|
|3/25/2015||Jeffrey T Klenda||Director||Buy||25,000||$0.16||$3,875.00|
|3/23/2015||Dawn C Willoughby||COO||Sell||5,440||$112.00||$609,280.00|| |
|3/16/2015||Stephen Robb||CFO||Sell||25,279||$109.49||$2,767,797.71|| |
|2/12/2015||Nikolaos A Vlahos||COO||Sell||16,018||$108.01||$1,730,104.18|| |
|2/10/2015||Frank A Tataseo||EVP||Sell||86,087||$107.01||$9,212,169.87|| |
|2/6/2015||Donald R Knauss||Chairman||Sell||272,780||$106.83||$29,141,087.40|| |
|1/9/2015||James E Foster||EVP||Sell||19,048||$106.68||$2,032,040.64|| |
|1/5/2015||Jacqueline P Kane||SVP||Sell||23,534||$103.76||$2,441,887.84|| |
|12/22/2014||Donald R Knauss||Chairman||Sell||270,853||$104.06||$28,184,963.18|| |
|12/8/2014||Nikolaos A Vlahos||COO||Sell||7,394||$99.60||$736,442.40|| |
|11/26/2014||James E Foster||EVP||Sell||15,315||$99.74||$1,527,518.10|| |
|11/26/2014||Thomas D Johnson||VP||Sell||25,006||$99.52||$2,488,597.12|| |
|11/25/2014||Jacqueline P Kane||SVP||Sell||43,430||$99.50||$4,321,285.00|| |
|11/13/2014||Dawn C Willoughby||COO||Sell||4,034||$102.02||$411,548.68|| |
|11/13/2014||Michael R Costello||SVP||Sell||16,348||$102.00||$1,667,496.00|| |
|11/3/2014||George C Roeth||COO||Sell||198,159||$99.46||$19,708,894.14|| |
|9/22/2014||Jacqueline P Kane||SVP||Sell||43,960||$97.00||$4,264,120.00|| |
|8/25/2014||Benno O Dorer||COO||Sell||2,505||$89.12||$223,245.60|| |
|6/9/2014||Thomas D Johnson||VP||Sell||23,737||$89.44||$2,123,037.28|| |
|5/20/2014||Thomas Britanik||CMO||Sell||1,779||$88.48||$157,405.92|| |
|5/8/2014||Thomas Britanik||CMO||Sell||21,320||$88.00||$1,876,160.00|| |
|4/29/2014||Wayne Delker||SVP||Sell||14,819||$92.00||$1,363,348.00|| |
|3/27/2014||Dawn Willoughby||SVP||Sell||2,595||$90.00||$233,550.00|| |
|12/3/2013||Grant Lamontagne||SVP||Sell||71,860||$93.01||$6,683,698.60|| |
|11/22/2013||Jon Balousek||SVP||Sell||3,125||$93.72||$292,875.00|| |
|11/7/2013||Thomas P Britanik||CMO||Sell||5,834||$92.03||$536,903.02|| |
|11/5/2013||Carolyn M Ticknor||Director||Sell||8,000||$90.01||$720,080.00|| |
|10/29/2013||Benno O Dorer||COO||Sell||15,577||$90.25||$1,405,824.25|| |
|10/29/2013||Frank A Tataseo||EVP||Sell||25,200||$90.27||$2,274,804.00|| |
|7/9/2013||Benno O Dorer||COO||Sell||25,714||$85.14||$2,189,289.96|| |
|6/14/2013||Frank A Tataseo||EVP||Sell||1,197||$85.17||$101,948.49|| |
|6/3/2013||Thomas P Britanik||CMO||Sell||2,278||$83.59||$190,418.02|| |
|5/29/2013||Tully M Friedman||Director||Sell||3,000||$84.79||$254,370.00|| |
|5/24/2013||Michael R Costello||VP||Sell||1,217||$85.98||$104,637.66|| |
|5/16/2013||Thomas P Britanik||CMO||Sell||34,258||$87.81||$3,008,194.98|| |
|5/15/2013||George J Harad||Director||Sell||5,497||$87.19||$479,283.43|| |
|5/15/2013||Grant J Lamontagne||SVP||Sell||19,350||$87.62||$1,695,447.00|| |
|5/7/2013||Nikolaos A Vlahos||SVP||Sell||3,769||$86.15||$324,699.35|| |
|2/22/2013||Larry Peiros||COO||Sell||77,200||$83.00||$6,407,600.00|| |
|2/1/2013||Larry Peiros||COO||Sell||10,678||$79.24||$846,124.72|| |
|2/1/2013||Stephen Robb||CFO||Sell||8,781||$79.29||$696,245.49|| |
|12/10/2012||George J Harad||Director||Buy||3,000||$75.95||$227,850.00|| |
|12/4/2012||Laura Stein||SVP||Sell||26,780||$76.34||$2,044,385.20|| |
Headline Trends for Clorox Company (The) (NYSE:CLX)
Latest Headlines for Clorox Company (The) (NYSE:CLX)
Loading headlines, please wait.
Clorox Company (The) (CLX) Chart for Monday, October, 23, 2017